Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
Wild-type blocking PCR followed by direct sequencing offers a highly sensitive method of detection for low frequency somatic mutations in a variety of sample types.
Accurate detection and identification of low frequency mutations can be problematic when assessing residual disease after therapy, screening for emerging resistance mutations during therapy, or when patients have few circulating tumor cells. Wild-type blocking PCR followed by sequencing analysis offers high sensitivity, flexibility, and simplicity as a methodology for detecting these low frequency mutations. By adding a custom designed locked nucleic acid oligonucleotide to a new or previously established conventional PCR based sequencing assay, sensitivities of approximately 1 mutant allele in a background of 1,000 WT alleles can be achieved (1:1,000). Sequencing artifacts associated with deamination events commonly found in formalin fixed paraffin embedded tissues can be partially remedied by the use of uracil DNA glycosylase during extraction steps. The optimized protocol here is specific for detecting MYD88 mutation, but can serve as a template to design any WTB-PCR assay. Advantages of the WTB-PCR assay over other commonly utilized assays for the detection of low frequency mutations including allele specific PCR and real-time quantitative PCR include fewer occurrences of false positives, greater flexibility and ease of implementation, and the ability to detect both known and unknown mutations.
Sanger sequencing has traditionally been the gold standard in testing for both known and unknown somatic mutations. One of the limitations of Sanger sequencing is its limit of detection (~ 10 - 20% mutant allele in a background of WT)1. This level of sensitivity is inappropriate for detecting low level somatic mutations that may be present in samples from premalignant tissues or patients with few circulating tumor cells, or when bone marrow (BM) is patchy. This also makes assessing residual disease after therapy or detecting emerging resistance mutations during therapy difficult by conventional sequencing alone2. By repl....
Ethics Statement: All testing of human samples was performed after obtaining Institutional Review Board (IRB) approval.
1. DNA Extraction from FFPE Tissue, Peripheral Blood, and Bone Marrow Aspirate
A conceptual overview of WTB-PCR during extension is presented in Figure 1. Because a single nucleotide mismatch in the blocker-DNA hybrid greatly decreases its melting temperature (ΔTm=20 - 30 °C), amplification of the WT allele is blocked while mutant template DNA is free to complete extension17. In this manner, mutant DNA is amplified exponentially while WT DNA is amplified linearly.
The WTB-PCR assay described here uses a generic set of primers with a blocking oligo designed to block amplification of WT DNA during extension (Figure 1). The WTB-PCR product is then sequenced for mutational analysis. The utility of WTB-PCR/Sanger lies in its simplicity, high-sensitivity, and high-throughput. Using the guidelines described here, most existing Sanger based assays can be simply modified via the addition of a blocking oligonucleotide to greatly increase sensitivity. In the example assay pr.......
The authors have no acknowledgements.
....Name | Company | Catalog Number | Comments |
1.5 or 2 ml Safe-Lock microcentrifuge tubes | Eppendorf | 05-402-25 | |
100% alcohol | VWR | 89370-084 | Histology grade; 91.5% Ethanol, 5% Isopropyl alcohol, 4.5% Methyl alcohol |
3730XL sequencer | ABI | or equivalent | |
Agencourt AMPure XP | Beckman Coulter | A63881 | For magnetic bead PCR purification |
Aluminum sealing foils | GeneMate | T-2451-1 | For PCR and cold storage |
BigDye Terminator v3.1 Cycle sequencing kit | Life Technologies | 4337455 | For bi-directional sequencing. With 5X Sequencing Buffer |
Centrifuge 5804 Series | Eppendorf | A-2-DWP rotor (for PCR plate) | |
Cold plate for 96 well plates | Eppendorf | Z606634 | |
DNAse, RNAse-free, ultra-pure water | |||
dNTPs (100mM) | Invitrogen | 10297-117 | |
DynaMag-96 Side-Skirted Magnet | Thermo Fisher Scientific | 12027 | For use in PCR Purification. |
Ethanol Absolute | Sigma | E7023 | 200 proof, for molecular biology |
Exiqon website Oligo Tools | www.exiqon.com/oligo-tools | ||
FastStart Taq DNA polymerase (5 U/ul) | Roche | 12032937001 | With10X concentrated PCR reaction buffer, with 20 mM MgCl2 |
Gel electrophoresis apparatus | 2% agarose gel | ||
GeneRead DNA FFPE extraction Kit | Qiagen | 180134 | Contains uracil DNA glycosylase necessary for reducing sequencing artifacts |
Hi-Di Formamide | ABI | 4311320 | For sequencing. |
LNA oligonucleotide | Exiqon | 500100 | 5'-TCAGA+AG+C+G+A+C+T+G+A+T+CC/invdT/ (+N = LNA bases) |
M13-F Sequencing Primer | ABI | 5'-tgt aaa acg acg gcc agt | |
M13-R Sequencing Primer | ABI | 5'-cag gaa aca gct atg acc | |
Mastercycler Pro S Thermocycler | Eppendorf | E950030020 | |
Microcentrifuge Model 5430 | Eppendorf | FA-45-30-11 rotor (for 1.5/2 ml microcentrifuge tubes) | |
NanoDrop 2000 Spectrophotometer | Thermo Fisher Scientific | ||
PCR forward primer | IDT | 5'-tgt aaa acg acg gcc agt TGC CAG GGG TAC TTA GAT GG | |
PCR reverse primer | IDT | 5'-cag gaa aca gct atg acc GGT TGG TGT AGT CGC AGA CA | |
PCR plates | GeneMate | T-3107-1 | |
Pipettors | 20, 200, 1000 µl | ||
Plate septa, 96 well | ABI | 4315933 | |
QIAamp DNA Mini Kit | Qiagen | 51304 | For BM aspirate and peripheral blood |
SeqScape Sortware v3.0 | ABI | 4474978 | For sequencing analysis |
Slide basket | |||
Sodium Acetate (3M, pH 5.2) | Sigma | S7899 | |
Sterile filtered pipette tips | 20, 200, 1000 µl | ||
Thermomixer C | Eppendorf | 5382000023 | |
Vortex genie | Scientific Industries | SI-0236 | |
Wash reservoir | ~1000 ml | ||
Xylene | VWR | 89370-088 | Histology grade |
This article has been published
Video Coming Soon